Ligand(LGND) - 2023 Q3 - Earnings Call Transcript

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Simon Latimer - Head-Investor Relations Todd Davis - Chief Executive Officer Matthew Korenberg - President and Chief Operating Officer Tavo Espinoza - Chief Financial Officer Paul Hadden - Senior Vice President-Investments Conference Call Participants Jack Cole - Craig-Hallum Capital Group Lawrence Solow - CJS Securities Operator Thank you for standing by. My name is Danika and I'll be ...